Back
Corporate News
Parmax Pharma to announce Q2 2026 results Friday, August 14, followed by trading halt
11-Aug-2026, 04:09
Parmax Pharma Limited will hold a board meeting on Friday, August 14, 2026, to approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. Trading in the company's securities will be closed for forty-eight hours after the announcement of the financial results, as per SEBI regulations.
Parmax Pharma Limited will hold a board meeting on Friday, August 14, 2026, to approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. Trading in the company's securities will be closed for forty-eight hours after the announcement of the financial results, as per SEBI regulations.